Name: Telix Pharmaceuticals Limited (TLX) Balance Sheet
Creator: FinSpry

Telix Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Telix Pharmaceuticals Limited (TLX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	441.71	83.96	79.07	15.97	60.13
Cash & Short-Term Investments	441.71	83.96	79.07	15.97	60.13
Accounts Receivable	86.71	44.13	31.21	0.53	10.95
Inventory	23.72	11.79	5.76	2.50	0.49
Other Current Assets	6.86	7.10	1.70	1.03	0.66
Total Current Assets	571.19	158.41	117.74	34.46	72.23
Non-Current Assets
Property, Plant & Equipment (Net)	33.78	20.77	12.80	4.59	3.72
Long-Term Investments	3.79	6.47	0.00	0.00	0.00
Goodwill	66.32	3.30	3.75	2.97	3.26
Intangible Assets	192.45	71.41	36.34	37.43	42.40
Other Non-Current Assets	46.38	0.40	0.22	0.15	0.14
Total Non-Current Assets	371.77	118.17	55.87	45.14	0.00
Total Assets	942.96	276.58	173.56	79.60	121.76
Current Liabilities
Accounts Payable	42.72	22.37	11.42	8.61	4.48
Short-Term Debt	11.81	0.66	0.00	0.01	0.20
Current Portion of Long-Term Debt	11.75	0.66	0.00	0.00	0.20
Accrued Liabilities	33.18	28.61	25.23	8.48	1.92
Deferred Revenue	6.99	7.49	3.63	4.51	2.55
Other Current Liabilities	53.42	25.31	12.46	4.45	5.85
Total Current Liabilities	205.77	112.46	58.15	27.53	15.40
Non-Current Liabilities
Long-Term Debt	343.14	5.59	2.25	1.38	0.07
Deferred Tax Liabilities	5.83	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	18.91	37.88	37.45	16.71	22.31
Total Non-Current Liabilities	383.86	62.67	61.08	50.51	0.00
Total Liabilities	589.63	175.13	119.18	78.04	60.80
Stockholders' Equity
Common Stock	369.31	304.20	252.14	123.84	128.88
Retained Earnings	-132.43	-179.64	-185.42	-125.75	-71.72
Accumulated Other Comprehensive Income	114.66	-22.95	-12.34	3.47	3.79
Additional Paid-in Capital	371.09	304.04	0.00	0.00	0.00
Shares Outstanding	334.72	323.73	316.34	285.07	0.00
Total Stockholders' Equity	353.33	101.45	54.38	1.56	60.96
Total Liabilities & Equity	942.96	276.58	173.72	79.60	0.00